These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34784149)

  • 1. Challenges with implementing the Diabetes Prevention Program for Medicare beneficiaries in an integrated health system.
    Gruß I; Firemark A; Papajorgji-Taylor D; Fitzpatrick SL
    Am J Manag Care; 2021 Nov; 27(11):e400-e403. PubMed ID: 34784149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stakeholder analysis: Medicare Diabetes Prevention Program awareness and implementation.
    Turk MT; Ritchie ND; Jakub K
    Am J Manag Care; 2023 Jun; 29(6):308-312. PubMed ID: 37341978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated number of eligible Part B beneficiaries for the medicare diabetes prevention program at the county level and by urban-rural classification.
    Ng BP; Cheng YJ; Rutledge S; Cannon MJ; Zhang P; Smith BD
    PLoS One; 2020; 15(11):e0241757. PubMed ID: 33170867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare Diabetes Prevention Program: where are the suppliers?
    Ritchie ND; Sauder KA; Gritz RM
    Am J Manag Care; 2020 Jun; 26(6):e198-e201. PubMed ID: 32549070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Medicare Diabetes Prevention Coverage May Limit Beneficiary Access and Widen Health Disparities.
    Ritchie ND; Gritz RM
    Med Care; 2018 Nov; 56(11):908-911. PubMed ID: 30312286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from Launching the Diabetes Prevention Program in a Large Integrated Health Care Delivery System: A Case Study.
    Rehm CD; Marquez ME; Spurrell-Huss E; Hollingsworth N; Parsons AS
    Popul Health Manag; 2017 Aug; 20(4):262-270. PubMed ID: 28075695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing access and impact of the Medicare Diabetes Prevention Program using telehealth: a narrative review.
    Ritchie ND; Turk MT
    Mhealth; 2024; 10():10. PubMed ID: 38323146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring Reimbursement Options for the National Diabetes Prevention Program: Lessons Learned From a Pilot Project in Los Angeles, 2014-2018.
    Mosst JT; DeFosset A; Sivashanmugam M; Kuo T
    J Public Health Manag Pract; 2021 May-Jun 01; 27(3):E119-E125. PubMed ID: 32011598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A digital divide in the COVID-19 pandemic: information exchange among older Medicare beneficiaries and stakeholders during the COVID-19 pandemic.
    Castillo A; Rivera-Hernandez M; Moody KA
    BMC Geriatr; 2023 Jan; 23(1):23. PubMed ID: 36635684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Identification and Referral of Adults With Prediabetes to a Diabetes Prevention Program.
    Holliday CS; Williams J; Salcedo V; Kandula NR
    Prev Chronic Dis; 2019 Jun; 16():E82. PubMed ID: 31255186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing an integrated care management program in community pharmacies: A focus on medication management services.
    Smith MG; Ferreri SP; Brown P; Wines K; Shea CM; Pfeiffenberger TM
    J Am Pharm Assoc (2003); 2017; 57(2):229-235.e1. PubMed ID: 28173993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers associated with the delivery of Medicare-reimbursed diabetes self-management education.
    Powell MP; Glover SH; Probst JC; Laditka SB
    Diabetes Educ; 2005; 31(6):890-9. PubMed ID: 16288096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare underpayment for Diabetes Prevention Program: implications for DPP suppliers.
    Parsons AS; Raman V; Starr B; Zezza M; Rehm CD
    Am J Manag Care; 2018 Oct; 24(10):475-478. PubMed ID: 30325189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of the YMCA Diabetes Prevention Program throughout an Integrated Health System: A Translational Study.
    Adams R; Hebert CJ; Mcvey L; Williams R
    Perm J; 2016; 20(4):15-241. PubMed ID: 27828773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019.
    McCoy RG; Van Houten HK; Deng Y; Mandic PK; Ross JS; Montori VM; Shah ND
    JAMA Netw Open; 2021 Feb; 4(2):e2035792. PubMed ID: 33523188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
    Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
    Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral Health Integration With Primary Care: Implementation Experience and Impacts From the State Innovation Model Round 1 States.
    Beil H; Feinberg RK; Patel SV; Romaire MA
    Milbank Q; 2019 Jun; 97(2):543-582. PubMed ID: 30957311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a group-based diabetes prevention program within a healthcare delivery system.
    Azar KMJ; Nasrallah C; Szwerinski NK; Petersen JJ; Halley MC; Greenwood D; Romanelli RJ
    BMC Health Serv Res; 2019 Oct; 19(1):694. PubMed ID: 31615525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital Divide Among Medicare Beneficiaries and the Diabetes Prevention Program.
    Ng BP; Hawkins GT; Massey M; LaManna JB; Park C
    Am J Prev Med; 2024 Nov; 67(5):746-752. PubMed ID: 38909662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative care models for high-cost Medicare beneficiaries: delivery system and payment reform to accelerate adoption.
    Davis K; Buttorff C; Leff B; Samus QM; Szanton S; Wolff JL; Bandeali F
    Am J Manag Care; 2015 May; 21(5):e349-56. PubMed ID: 26167783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.